medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	Shared decision making in inflammatory bowel disease: a qualitative study with patients, gastroenterologists, and nurses. BMC Health Serv Res Schoefs E, Michiels L, Straetemans N, Ferrante M, Verstockt B, Sabino J, Debrun L, Loddewijkx E, Van Audenhove C, Vermeire S, Huys I. PMID: 42907825 [PubMed - indexed for MEDLINE]
	Very early onset inflammatory bowel disease in Jordan: a single-center case series of clinical, genetic, and therapeutic features. BMC Pediatr Altamimi E, Almomani H, Alsmadi A, Issi N, Shurman M. PMID: 42907806 [PubMed - indexed for MEDLINE]
	Risk factors and prediction model of renal dysfunction in patients with inflammatory bowel disease: a retrospective cohort study. BMC Gastroenterol Zhou Y, Sun K, Chen X, Shen X, Chen J, Wang L, Chen C, Wang H, Wan Y, Yang L, Li L. PMID: 42907758 [PubMed - indexed for MEDLINE]
	Comparative efficacy and safety of subcutaneous vedolizumab versus other targeted inflammatory bowel therapies in patients with moderate to severe ulcerative colitis: a network meta-analysis update. BMC Gastroenterol Jiang J, Wojtowicz A, Uyei J, Jin H, Lindsley K, Sanchirico M. PMID: 42907748 [PubMed - indexed for MEDLINE]
	Is hemorrhoidal surgery really unsafe in inflammatory bowel disease? Results from the HEAD-IBD multicenter study on behalf of IG-IBD. Tech Coloproctol Felice C, Pugliese D, Gallo G, Di Tanna GL, Ascolani M, Sica GS, Bellato V, Franco M, Scaldaferri F, Parisio L, Colombo F, Bondurri A, Guerci C, Aratari A, Festa S, Ascari F, Savarino EV, Grossi U. PMID: 42907681 [PubMed - indexed for MEDLINE]
	Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study. Dig Liver Dis Jeong TJ, Kwon Y, Kim YZ, Kim ES, Choe YH, Kim MJ. PMID: 42907314 [PubMed - as supplied by publisher]
	Poria cocos polysaccharides as a carbon source promotes the proliferation of Parabacteroides distasonis to ameliorate ulcerative colitis: A mechanistic study based on the secondary bile acid-TGR5 axis. Int J Biol Macromol Zhang Y, Fang Y, Chen Y, Chen Q, Liu W, Xu M, Xing L, Wang R, Wang L, Yu N, Peng D, Wang Y, Chen W. PMID: 42904778 [PubMed - indexed for MEDLINE]
	Upadacitinib in Colonic Crohn's Disease: A Narrative Review of Mechanistic Rationale, Clinical Trial Evidence, and Real-World Outcomes. Middle East J Dig Dis VatanParast Y. PMID: 42903373 [PubMed]
	Acetylation-ubiquitination crosstalk in NLRP3-gasdermin pyroptosis: a substrate-state framework with relevance to ulcerative colitis. Front Immunol Zhao Y, Zhu X, Lu E, Meng H. PMID: 42903324 [PubMed - indexed for MEDLINE]
	Laparoscopic surgery is associated with reduced long-term reoperation risk in Crohn's disease. Tech Coloproctol Schlager L, Hamidi M, Dengler T, Fallmann B, Krall C, Schreiner P, Reinisch W, Hansmann A, Bergmann M, Stift A, Unger LW. PMID: 42902052 [PubMed - indexed for MEDLINE]
	Perianal fistulizing Crohn's disease: emerging biology, therapeutics, and roadmap for precision treatment. Trends Pharmacol Sci Solitano V, Bertani L, Di Salvo C, Ribaldone DG, Antonioli L. PMID: 42901811 [PubMed - as supplied by publisher]
	Risk Factors for Early Intestinal Resection in Pediatric Crohn's Disease: A Nationwide Cohort Study. J Surg Res Bajzát D, Imrei M, Nagy R, Párniczky A, Gede N, Hegyi P, Karoliny A, Szentannay J, Czelecz J, Cseh Á, Béres NJ, Tóth MM, Kovács M, Guthy I, Lásztity N, Kadenczki O, Szakos E, Sz, Vass N, Tárnok A, Müller KE. PMID: 42900965 [PubMed - as supplied by publisher]
	Targeting pyroptosis in intestinal and systemic inflammatory diseases: mechanisms and therapeutic opportunities. Mol Biol Rep Li J, Chen Y, Yu Q, Fu X, Sun J, Zhu L. PMID: 42900259 [PubMed - indexed for MEDLINE]
	Noninvasive evaluation of liver fibrosis in newly diagnosed pediatric Crohn's disease: Elastography and fibrotic biomarkers at diagnosis. Adv Clin Exp Med Medy, Stochel-Gaudyn A, Tomasik PJ, Zawartka A, Klimasz K, Kowalska-Duplaga K, W. PMID: 42899327 [PubMed - as supplied by publisher]
	Unlocking the therapeutic potential of traditional Chinese medicine in Crohn's disease: from multi-target mechanisms to clinical promise. Front Immunol Zhou M, Chen Y, Hu J, Guo X, Jin W. PMID: 42898763 [PubMed - indexed for MEDLINE]
	GART expression is associated with a proliferative and purine-metabolic ISC-like epithelial state in ulcerative colitis. Front Immunol Chong J, Ding H, Ma J, Li Y, Pan J, Li Y, Chen Y. PMID: 42898284 [PubMed - indexed for MEDLINE]
	Integrated genetic and functional analyses reveal the pathogenic effects of a novel STXBP3 variant in very-early-onset inflammatory bowel disease with immunodeficiency. Front Immunol Pan C, Zhang P, Tang W, Wang S, Huang Z, Lu X, Meng Y, Xia H, Wang L, Huang Y. PMID: 42898147 [PubMed - indexed for MEDLINE]
	Diagnostic accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) for inflammatory bowel disease: a systematic review and bivariate diagnostic meta-analysis. BMC Gastroenterol Yu T, Meng F, Ma K, Wang C. PMID: 42897465 [PubMed - indexed for MEDLINE]
	Comparative risk of incident Clostridioides difficile infection with vedolizumab versus antiâ€‘TNF in ulcerative colitis: A retrospective cohort study. Dig Liver Dis Huang J, Jiang Z, Deng J, Yao J, Peng X, Zhang Q, Zhi M, Zhang M, Liu T. PMID: 42897030 [PubMed - as supplied by publisher]
	Safety and tolerability of anti-toll-like receptor 3, monoclonal antibody PRV-300 in patients with moderate-to-severe ulcerative colitis: a randomized phase 1B clinical trial (PULSE). J Crohns Colitis Pokryszka J, Comer GM, Richmond CA, Leon F, Reinisch W. PMID: 42896861 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 59166

Seite 1 von 2959



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung